Industry: Healthcare | Publish Date: 28-Nov-2024 | No of Pages: 417 | No. of Tables: 241 | No. of Figures: 211 | Format: PDF | Report Code : HC90
The global Animal Therapeutics and Diagnostics Market size was valued at USD 34.66 billion in 2020 and is predicted to reach USD 59.21 billion by 2030 with a CAGR of 5.5% from 2021-2030.
Animal therapeutics and diagnostics products include various instruments and consumables for the diagnosis, treatment, and prevention of ailments in animals. They play an important role in preventing serious epizootic diseases and are widely used for treating diseases such as anthrax, black quarter (black-leg), foot and mouth disease, rabies (mad dog disease), blue tongue, pox, and brucellosis of sheep, among others.
The diagnostic instruments include, small imaging devices such as positron emission tomography (PET) scanners, single-photon emission computed tomography (SPECT) scanners, laryngoscopes, ophthalmoscopes, and ENT equipment among others. Whereas, animal therapeutic products include drugs such as painkillers, tranquilizers, antibiotics and sedatives. These instruments and drugs.
The increasing number of veterinary facilities in developed regions, growing expenditure on animal health and pet insurance are factors augmenting the growth of the animal therapeutics and diagnostics market. Also, a large section of the global population depends on animal husbandry for their livelihood. This makes better animal healthcare a crucial factor for the prevention of adverse implications in animal dependent agriculture and farming.
Moreover, rising cases of obesity and chronic diseases such as bovine spongiform encephalopathy (BSE) among animals, along with increasing demand for animal vaccination due to the steady growth in pet ownership are some of the other factors boosting the growth of the pet therapeutics and diagnostics industry.
However, highly competitive meat and milk prices that pushes the animal owners to lower the input cost and lack of awareness regarding animal healthcare in developing and underdeveloped countries are hampering the growth of the animal therapeutics and diagnostics market. On the other hand, high growth prospects in these countries, rising demand for animal-derived food, growth in the adoption of companion animals, and progress in the research on therapeutic drugs and diagnostic instruments are expected to provide lucrative opportunities for the market players in the near future.
The global animal therapeutics and diagnostics market share is categorized on the basis of product type, animal type and geography. On the basis of product type, the market is segmented into animal therapeutic products and animal diagnostics products.
On the basis of animal type, the market is segmented as companion animals, sheep, poultry pigs, and cattle. Companion animals/pet animals are further divided into dogs, cats, etc. Based on geography, the market is further is categorized into North America, Europe, Asia-Pacific, and RoW.
At present, North America dominates the animal therapeutics and diagnostics market and is anticipated to maintain its dominance throughout the forecast period. This is attributed to factors such as the increasing prevalence of animal diseases and the rising adaptation of companion animals such as dogs and cats in countries like the U.S. and Canada.
Apart from this. the market in Europe is also expanding at a promising rate with the increasing number of veterinarians and growing awareness about animal diseases. As per a recent study, disease like appendicular osteoarthritis affects around 2,00,000 dogs every year in U.K. alone, which in turn propels the growth of animal therapeutics and diagnostics market in this region.
On the other hand, the Asia Pacific market for animal therapeutics and diagnostics is predicted to show consistent growth in terms of market revenue. This is due to the factors such as the emergence of various zoonotic diseases, rapid urbanization and increasing livestock population in this region.
The animal therapeutics and diagnostics industry consist of a number of major players including BioNote Inc, Heska Corp, IDEXX Laboratories Inc, IDvet, Randox Laboratories Ltd., SWISSAVANS AG, Teco Diagnostics, Thermo Fisher Scientific Inc., Virbac SA, Zoetis Inc., Thermo Fisher Scientific, Inc., bioMérieux S.A., Zoetis Inc., Bio-Rad Laboratories, Inc., Medical Bioscience GMBH, and Agrolabo SpA. Strategic alliances, acquisitions and innovations along with R&D are key strategies used by market players to maintain market dominance.
For instance, in July 2020, Bionote USA launched a slanted in vitro diagnostic test kit for the quantitative measurement of NTproBNP concentration in canine serum to its Vcheck product line. The Vcheck diagnostic product line includes immunoassay analyzers and tests for the veterinary market.
The report offers a quantitative analysis of the current animal therapeutics and diagnostics market estimations through 2021-2030 that assist in identifying the prevailing market opportunities to capitalize on.
It comprises of a deep dive analysis of the animal therapeutics and diagnostics market, including the current and future trends for depicting prevalent investment pockets in the report.
It shares information related to key drivers, restraints and opportunities and their impact on the animal therapeutics and diagnostics market.
It includes key market players, and market share, which helps understand their competitive analysis.
The competitive analysis of the market players along with their share in the animal therapeutics and diagnostics market.
The SWOT analysis and Porter's Five Forces model are elaborated in on the study.
Value chain analysis in the market study provides a clear picture of the stakeholder’s role.
Animal Diagnostics Products
Instruments
Consumables
Animal Therapeutics Products
Anti-Parasitic Drugs and Antibiotics
Anti-Inflammatory Drugs
Anesthetics
Other Drugs
Companion Animal
Cattle
Pigs
Poultry
Sheep
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
RoW
UAE
Saudi Arabia
South Africa
Brazil
Rest of RoW.
IDEXX Laboratories, Inc.
Thermo Fisher Scientific, Inc.
BioMérieux S.A.
Zoetis Inc.
Bio-Rad Laboratories, Inc.
Medical Bioscience, GMBH.
Agrolabo SpA.
BioNote Inc.
Heska Corp.
Randox Laboratories Ltd.
REPORT SCOPE AND SEGMENTATION:
Parameters |
Details |
Analysis Period |
2020–2030 |
Base Year Considered |
2020 |
Forecast Period |
2021–2030 |
Market Size Estimation |
Billion (USD) |
Market Segmentation |
By Product Type (Animal Diagnostics Products, Animal Therapeutics Products and Other Product Type), by Animal Type (Companion Animals, Cattle, Pigs, Poultry, and Sheep) |
Geographical Segmentation |
North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), Rest of the World (UAE, Saudi Arabia, South Africa, Brazil, Rest of RoW) |
Companies Profiled |
BioNote Inc, Heska Corp, IDEXX Laboratories Inc, IDvet, Randox Laboratories Ltd., SWISSAVANS AG, Teco Diagnostics, Thermo Fisher Scientific Inc., Virbac SA, Zoetis Inc., Thermo Fisher Scientific, Inc., bioMérieux S.A., Zoetis Inc., Bio-Rad Laboratories, Inc., Medical Bioscience GMBH, and Agrolabo SpA |